Ambroxol Hydrochloride Direct Oral Granules(Shandong Kecheng Pharma)

盐酸氨溴索直服颗粒(山东科成医药)

Report date: 2026/03/31 20:00:21

Base Information

Drug NameAmbroxol Hydrochloride Direct Oral Granules(Shandong Kecheng Pharma)
Drug Alias NameAmbroxol SR盐酸氨溴素Ziva盐酸溴环已胺醇Ambroxolum
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsRespiratory Tract Diseases
Approved Indications in ChinaRespiratory Tract Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2023/12/22
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A